The Role of ??-Blockers in the Treatment of Cardiomyopathy and Ischaemic Heart Failure
- 1 January 1994
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 47 (4), 31-40
- https://doi.org/10.2165/00003495-199400474-00006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpointJournal of the American College of Cardiology, 1993
- Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1991
- Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placeboThe American Journal of Medicine, 1990
- Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.Circulation, 1989
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.Circulation, 1989
- Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.1986
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.1985
- The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.1981
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979